426 related articles for article (PubMed ID: 28721885)
1. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.
Arthur DW; Winter KA; Kuerer HM; Haffty BG; Cuttino LW; Todor DA; Simone NL; Hayes SB; Woodward WA; McCormick B; Cohen RJ; Sahijdak WM; Canaday DJ; Brown DR; Currey AD; Fisher CM; Jagsi R; White J
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1028-1035. PubMed ID: 28721885
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
Arthur DW; Winter KA; Kuerer HM; Haffty B; Cuttino L; Todor DA; Anne PR; Anderson P; Woodward WA; McCormick B; Cheston S; Sahijdak WM; Canaday D; Brown DR; Currey A; Fisher CM; Jagsi R; Moughan J; White JR
JAMA Oncol; 2020 Jan; 6(1):75-82. PubMed ID: 31750868
[TBL] [Abstract][Full Text] [Related]
3. Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy.
Berrang TS; Olivotto I; Kim DH; Nichol A; Cho BC; Mohamed IG; Parhar T; Wright JR; Truong P; Tyldesley S; Sussman J; Wai E; Whelan T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1220-7. PubMed ID: 20971571
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
5. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma.
Rabinovitch R; Moughan J; Vicini F; Pass H; Wong J; Chafe S; Petersen I; Arthur DW; White J
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1054-1059. PubMed ID: 27869081
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
10. Can we predict plan quality for external beam partial breast irradiation: results of a multicenter feasibility study (Trans Tasman Radiation Oncology Group Study 06.02).
Kron T; Willis D; Link E; Lehman M; Campbell G; O'Brien P; Chua B
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):817-24. PubMed ID: 24064318
[TBL] [Abstract][Full Text] [Related]
11. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
[TBL] [Abstract][Full Text] [Related]
12. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
Bantema-Joppe EJ; Schilstra C; de Bock GH; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e471-7. PubMed ID: 22494592
[TBL] [Abstract][Full Text] [Related]
14. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
[TBL] [Abstract][Full Text] [Related]
15. Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer.
Hardy-Abeloos C; Xiao J; Oh C; Barbee D; Perez CA; Oratz R; Schnabel F; Axelrod D; Guth A; Braunstein LZ; Khan A; Choi JI; Gerber N
Breast Cancer Res Treat; 2023 Feb; 198(1):43-51. PubMed ID: 36604352
[TBL] [Abstract][Full Text] [Related]
16. Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.
Horst KC; Fasola C; Ikeda D; Daniel B; Ognibene G; Goffinet DR; Dirbas FM
Breast; 2016 Aug; 28():178-83. PubMed ID: 27322859
[TBL] [Abstract][Full Text] [Related]
17. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial.
Liss AL; Ben-David MA; Jagsi R; Hayman JA; Griffith KA; Moran JM; Marsh RB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):96-102. PubMed ID: 24613813
[TBL] [Abstract][Full Text] [Related]
18. Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.
Bergom C; Kelly T; Morrow N; Wilson JF; Walker A; Xiang Q; Ahn KW; White J
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):821-8. PubMed ID: 22208973
[TBL] [Abstract][Full Text] [Related]
19. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
